Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Oncotarget|August 17, 2016
Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 systemBenjamin Garcia-Bloj, Colette Moses, Agustin Sgro, et al.
Oncogenesis|October 7, 2022
A MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancerMijeong Kim, Manjot Singh, Bum-Kyu Lee, et al.
Chemical Science|April 29, 2017
Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNAJessica A Kretzmann, Diwei Ho, Cameron W Evans, et al.
Oncogene|August 5, 2018
Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancersEdina Wang, Anabel Sorolla, Paula T Cunningham, et al.
Chemical Science|October 8, 2019
Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymersJessica A Kretzmann, Cameron W Evans, Colette Moses, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 22, 2023
Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast CancerCharlene Waryah, Joseph Cursons, Momeneh Foroutan, et al.
The Journal of Pathology|May 15, 2026
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profileKathleen I Pishas, Karla J Cowley, Evanny Marinovic, et al.
Nature Communications|March 27, 2021
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancerEmily Golden, Rabab Rashwan, Eleanor A Woodward, et al.
Pageof 6